Status:
COMPLETED
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy
Lead Sponsor:
Jun Zhang
Conditions:
Breast Cancer
Pectoral Nerves Block
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The aim of this randomized controlled trial (RCT) is to assess the Quality of Recovery (QoR) in Breast-conserving Surgery (BCS) with Sentinel Lymph Node Biopsy (SLNB) using Pectoral Nerves (PECS) Bloc...
Detailed Description
This study is a randomized controlled trial, with a 1:1 ratio for grouping. The experimental group is the T group, receiving Pecs II combined with intercostal nerve block, while the control group is t...
Eligibility Criteria
Inclusion
- Patients scheduled for breast-conserving surgery with sentinel lymph node biopsy.
- Age between 18 and 70 years.
- Body Mass Index (BMI) \< 30 kg/m2.
- American Society of Anesthesiologists (ASA) classification grade I-III.
Exclusion
- Contraindications to regional anesthesia: site infection at the puncture site, allergy to local anesthetics, coagulation disorders, or bleeding risks.
- Impaired liver or kidney function.
- Pregnancy, lactation, possibility of pregnancy, or planned pregnancy.
- Preoperative use of analgesic drugs, history of chronic pain, or history of opioid abuse.
- Mental illness.
- Patients who refuse to participate.
- Patients deemed unsuitable for the clinical trial by the researchers.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06120439
Start Date
December 1 2023
End Date
May 15 2024
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032